Combination denosumab and high dose teriparatide for postmenopausal osteoporosis (DATA-HD): a randomised, controlled phase 4 trial

Tsai, J.N., Lee, H., David, N.L. et al. (2 more authors) (2019) Combination denosumab and high dose teriparatide for postmenopausal osteoporosis (DATA-HD): a randomised, controlled phase 4 trial. The Lancet Diabetes & Endocrinology, 7 (10). pp. 767-775. ISSN 2213-8587

Metadata

Item Type: Article
Authors/Creators:
Copyright, Publisher and Additional Information:

© 2019 Elsevier Ltd. This is an author produced version of a paper subsequently published in Lancet Diabetes and Endocrinology. Uploaded in accordance with the publisher's self-archiving policy. Article available under the terms of the CC-BY-NC-ND licence (https://creativecommons.org/licenses/by-nc-nd/4.0/).

Dates:
  • Published (online): 22 August 2019
  • Published: October 2019
Institution: The University of Sheffield
Academic Units: The University of Sheffield > Sheffield Teaching Hospitals
Depositing User: Symplectic Sheffield
Date Deposited: 31 Jan 2020 14:51
Last Modified: 22 Feb 2020 01:38
Status: Published
Publisher: Elsevier BV
Refereed: Yes
Identification Number: 10.1016/s2213-8587(19)30255-4
Related URLs:
Open Archives Initiative ID (OAI ID):

Download

Export

Statistics


CORE (COnnecting REpositories)